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Wall Shear Stress in the Aortopathy
Associated With Bicuspid Aortic Valves*Francis G. Spinale, MD, PHD,y Ann F. Bolger, MDzH ighly prevalent and commonly associatedwith complications, bicuspid aortic valve(BAV) disease presents a more signiﬁcant
burden than any other congenital heart disease (1).
Although the individual course is variable, many
patients eventually require surgical intervention
to address valve dysfunction or aortic aneurysm
(2,3).
The aortic involvement in BAV has been attributed
to an intrinsic, genetic abnormality and may be en-
countered with or without functional impairment of
the valve. The presence, severity, and location of
aortic involvement is variable, which begs an impor-
tant question: Beyond the genetic predisposition to
dilation, how and to what extent do long-term he-
modynamic conditions in the aorta contribute to the
incidence, progression, and outcomes of aortic re-
modeling in BAV patients? Intrinsic or acquired ab-
normalities of the vascular wall at multiple sites
are known to be exacerbated by hemodynamic
conditions, including systemic hypertension and
hyperdynamic systolic ejection. In this issue of
the Journal, Guzzardi et al. (4) examine abnormal
local hemodynamics and their relation to potential
mechanisms contributing to aortic root dilation in
BAV patients.SEE PAGE 892
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FORM FOLLOWS FUNCTION
The aortic wall’s normal structure is highly organized
with a very rigid architecture of elastic ﬁbers and sur-
rounding matrix. Recent studies have identiﬁed an
induction/imbalance of proteolytic pathways in pa-
tients with ascending aortic aneurysms (5–7). In
resected aortic samples from patients with BAV
and ascending aneurysms, overall matrix metal-
loproteinase (MMP) activity has been reported to be
increasedmore than 3-fold from referent normal aortic
specimens (6). The MMPs constitute a large family of
proteolytic enzymes with a diversity of substrates, but
the relative levels of some more common MMP types,
such as MMP-2 and MMP-9, are altered in BAV/aneu-
rysm specimens (5,6). MMP induction and activity are
regulated in part by endogenous tissue inhibitors of
the MMPs (TIMPs). The 4 known TIMPs are differen-
tially regulated in pathophysiological conditions and
have dissimilar effects on cell viability, growth, and
matrix remodeling (8). In the context of BAV and aortic
aneurysms, a dysregulation of these TIMPs appears to
occur, concomitant with a shift inMMP expression and
activity (5–7). Thus, a shift in the MMP/TIMP balance
within the aorta of BAV patients most certainly con-
tributes to changes in aortic wall matrix structure and
composition, and the aortic aneurysm development
and progression. What remains unclear, however, is
what are the biological/biophysical stimuli driving the
imbalance in theMMP/TIMP portfolio in BAV patients?
Although the stimuli are likely to be multifactorial, the
study by Guzzardi et al. (4), provides new insight on a
biophysical stimulus that may propel changes in local
matrix homeostasis and, in turn, ascending aortic
structure: wall shear stress (WSS). They found that in
regions of high WSS, elastin content and structure
were severely disrupted compared with distal regions
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902of lower WSS. Moreover, these regional differences in
WSS patterns and elastin content and structure were
associated with a shift in the expression of speciﬁc
MMPs and TIMPs. These ﬁndings provide additional
insight into how alterations in local ﬂow dynamics in
BAV patients may be transduced into proteolytic
events, which in turn drive adverse aortic remodeling.
Although the study by Guzzardi et al. (4) is asso-
ciative and derived from a set of measurements at 1
point in time, there are other studies that support the
postulate that regional changes in mechanical stress
caused by a BAV can induce matrix proteolysis within
the ascending aorta (6,9). In an ex vivo porcine aortic
valve preparation, the WSS caused by BAV mor-
phology induced changes in MMP/TIMP expression
levels (9). In resected aortic samples from BAV pa-
tients with ascending aneurysms, different MMP/
TIMP expression proﬁles were observed in patients
with different patterns of aortic valve fusions (6),
providing indirect evidence that differences in local
ﬂow patterns and WSS likely contributed to these
changes in matrix proteolytic potential.
However, it is unlikely that changes in local WSS are
the only driving force for changes in aortic structure in
patients with BAV. First, this is a congenital malfor-
mation and thus changes in gene expression and
development patterns likely exist. Second, a number of
polymorphisms in bothMMP and TIMP sequences have
been identiﬁed, which may predispose patients to an
acceleration of aortic aneurysms (10). Third, the
expression of certain MMP types in patients with
thoracic aortic aneurysms with normal aortic valves, as
well as with BAVs, are associated with cytokine
receptor-mediated pathways (5–7), suggesting local
inﬂammatory cascades may be operative. What is clear
is that changes in MMP/TIMP proﬁles and subsequent
degradation of the aortic matrix is a likely common
pathway for thoracic aortic aneurysmdevelopment and
progression. The new study by Guzzardi et al. provides
evidence that, in BAV patients, an additional stimulus
that may drive a feed-forward effect on matrix prote-
olysis within the ascending aorta is changes in WSS.
AORTIC FLOW AND ESTIMATION OF WSS
Recent work using 4-dimensional ﬂow visualization
with cardiac magnetic resonance imaging (4D CMR)
has conﬁrmed that aortic ﬂow is distorted in the
setting of BAV and/or aortic dilation. Altered blood
ﬂow direction and velocity, with changes in ﬂow
asymmetry, helicity, and reversal, are ﬁndings asso-
ciated with BAV and other aortic aneurysm (11). The
spatiotemporal characteristics of distorted ﬂow in the
setting of aortic valve dysfunction and abnormalaortic geometry can be expected to result in altered
WSS, which is an estimate derived from the velocity
data from 4D CMR. One of the lessons of recent work
on aortic 4D ﬂow is that regions of elevated WSS are
not readily predicted by jet direction alone. As wall
shear is the force parallel to the wall, the location and
degree of turning of ﬂow in the ascending aorta and
root will inﬂuence where high velocities occur along
the wall, thereby increasing the WSS in regions not
directly impacted by a jet from a stenotic valve.
Among the approaches to studying the regional he-
modynamic forces on the proximal aorta, shear forces
are appealing as they have well-recognized impacts on
vascular function and disease (12,13). Shear can be
studied during a systolic interval, as in Guzzardi’s
study (4) where high shear was assumed to be themost
relevant; low shear, shear gradients, and oscillation in
shear have also been associated with vascular
dysfunction and atherogenesis. Diastolic wall shear is
also abnormally high in the proximal aorta in BAV pa-
tients and will reﬂect peripheral vascular properties as
well (14).Whether systolicWSS alonewould be the best
target to deﬁne the hemodynamic exacerbators of BAV
aortopathy has not been proven. WSS estimated at the
clinical stage where surgery is indicated selects a pa-
tient group with signiﬁcant longstanding hemody-
namic abnormalities; the degree to which wall
vulnerability and abnormal forces have combined to
create aortic dilation is difﬁcult to parse at this single
time point. By this late stage, the shape, the ﬂow, and
the load are all likely abnormal, and it is not surprising
that this is reﬂected in the WSS.
The 4D CMR methods to estimate WSS used in this
study and other studies share well-recognized limi-
tations. Limited spatial resolution, partial volume
effects, and numerical derivation of the velocity ﬁeld
are sources of inaccuracy when measuring event at
the ﬂow–wall interface, and are likely to introduce
underestimations in WSS (15). The degree of under-
estimation is more marked with increased WSS (16).
The approach of comparing regions within the same
patient to minimize the inﬂuence of changeable load
or frequency avoids some, but not all, of the impor-
tant provisos about using these estimates of WSS.
INTEGRATION OF LOCAL
SHEAR STRESS MEASUREMENTS IN
PRE- AND POST-OPERATIVE BAV
Can a better understanding of 4D aortic ﬂow in BAV
inform patient assessment at other time points? Sur-
veillance and prediction of progression are important
in the care of these patients, and the opportunity
exists to include ﬂow analysis with the surveillance
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903imaging that patients undergo. In future deﬁnitions
of surveillance tools, WSS would need to be compared
with other ﬂow characteristics. In a 4-year follow-up
study of patient with BAV, Hope et al. (11) found
that of their 4D CMR parameters of aortic ﬂow, ﬂow
displacement and peak velocity correlated with aortic
growth better than WSS. In a pediatric population,
Allen et al. (17) found that WSS did not correlate with
ascending aortic dilation in BAV patients, after con-
trolling for valvular disease severity.
Another important time point for BAV patients
is following surgery, where ﬂow redirection, inter-
position of graft material, and material property
changes related to surgical modiﬁcations might all be
expected to alter the post-operative WSS location and
extent, and potentially, the longer-term risk of the
retained aortic tissues. Preliminary work on patients
after valve-sparing aortic root replacement suggests
that elevated wall shear remains abnormal in other
distal aortic sites and correlates with the type of BAV
fusion (18). The beneﬁt of valve and/or aortic surgery
on retained aortic regions may be inﬂuenced by the
degree to which the surgically redirected ﬂow mod-
iﬁes high WSS. With the present state of knowledge,
aortic resection planning, based on pre-operative
distribution of relative WSS, is unsupported.
Interesting questions that arise from the novel 4D
CMR approaches to aortic ﬂow investigation remain
unanswered: What is the proportional impact of he-
modynamic abnormalities in earlier stages of patients
with BAV-associated aortopathy? Which of the many
ﬂow measures will be the most powerful predictors of
progression? And what is the impact of different
surgical approaches on the longer-term ﬂow-based
parameters? Understanding potentially modiﬁable
drivers of pre-operative and post-operative aortic
remodeling will require future investigations with
improved resolution that also reﬂect the other com-
mon, but highly relevant, hemodynamic parameters,
such as ejection parameters, heart rate, pressure
wave reﬂection, and systemic resistance.INTEGRATION OF HEMODYNAMICS
AND BIOMARKERS IN BAV PATIENTS:
A LOOK AHEAD
The conundrum facing clinicians with respect to pa-
tients with a BAV is the development of prognostic
models that can guide decisions regarding surgical
correction as well as long-term postoperative moni-
toring. The study by Guzzardi et al. (4) adds to the
growing body of knowledge that advanced imaging
approaches will likely provide key information in
developing new decision algorithms.
In addition to 4D CMR, advances in other imaging
modalities will likely provide improved resolution
and quantiﬁcation of regional mechanics within the
ascending aorta in BAV patients. Moreover, coupling
these imaging approaches with high-resolution, hy-
brid single-photon emission computed tomography/
computed tomography likely will provide the ability
to link changes in aortic structure to matrix proteol-
ysis (19). Speciﬁcally, using an MMP radiotracer
approach, it may be possible to localize sites of MMP
activation within the aortic aneurysm (19). Addition-
ally, biomarker proﬁling in patients with BAVs may
provide prognostic utility. An initial report suggests
that plasma proﬁling MMP/TIMP levels in BAV pa-
tients may yield a predictive modeling approach
which could be applied to future prospective studies
(7). Thus, future approaches in BAV patients are likely
to include multimodal techniques such as high-
resolution imaging of both regional hemodynamics
and proteolytic activity as well as biomarker proﬁling.
The study by Guzzardi et al. (4) is another incre-
mental step towards this more comprehensive
approach for patients with BAV.
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